Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB26FX7G1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,019
Award facts
- Contract value 100% obligated
- $5,019.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,019.48 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for TYMLOS 80 MCG Dose Pen Injectr 1.56ML. The contract is structured as a firm fixed-price delivery order with no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is dated November 10, 2025, with an ultimate completion date of November 12, 2025, and represents one of numerous delivery orders issued to the company by the Defense Logistics Agency's Medical Supply Chain division.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent IDC, awarded November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The PPV-G GEN V program authorizes the DLA to issue delivery orders for comprehensive pharmaceutical products and medical consumables to support the recurring medical supply needs of military healthcare facilities worldwide, with DMS Pharmaceutical Group's established performance on numerous prior delivery orders demonstrating its capability to fulfill the diverse pharmaceutical requirements of Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FX7G1?
SPE2DB26FX7G1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FX7G1 worth?
The government has obligated $5,019 on SPE2DB26FX7G1.
Is contract SPE2DB26FX7G1 an order under another contract?
Yes. SPE2DB26FX7G1 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB26FX7G1 competed?
The extent of competition for SPE2DB26FX7G1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award